FDA Approves Moderna’s RSV Vaccine for Some Younger Adults, Company Says
The vaccine was originally approved in 2024 for adults aged 60 and older.Federal regulators approved Moderna’s vaccine against Respiratory Syncytial Virus (RSV) for some adults as young as 18, the company…
